Difficulty: Medium
Average Score: 95%
Practice
A client with myasthenia gravis reports the occurrence of difficulty chewing. The physician prescribes pyridostigmine bromide (Mestinon) to increase muscle strength for this activity. The nurse instructs the client to take the medication at what time, in relation to meals?
Correct answer
D
Rationale
Pyridostigmine bromide is a cholinesterase inhibitor used to enhance muscle strength in myasthenia gravis, a condition characterized by muscle weakness, including difficulty chewing. Timing the medication administration is critical to maximize its effectiveness for specific activities like eating. Taking it 30 minutes before meals allows the drug to reach peak activity when the client needs improved muscle function to chew and swallow food comfortably. This timing aligns with the drug's pharmacokinetics, as it typically begins working within 30 to 60 minutes, ensuring optimal support during meals. Administering it after dinner or only in the morning would miss key eating times, while taking it upon arising might not sustain effects throughout the day. This strategic timing enhances the client's quality of life by addressing a primary symptom at the most relevant moments, reflecting a patient-centered approach to managing chronic neuromuscular conditions.